| Product Code: ETC10557132 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, the Netherlands saw steady growth in disease-modifying agents import shipments with key exporting countries being Germany, USA, Ireland, Belgium, and Italy. The market remained moderately concentrated with a Herfindahl-Hirschman Index (HHI) indicating stability. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 5.02%, with a slight uptick in the growth rate from 2023 to 2024 at 0.84%. This data suggests a resilient and evolving market for disease-modifying agents in the Netherlands, driven by imports from diverse international sources.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Disease Modifying Agents Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Disease Modifying Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Disease Modifying Agents Market - Industry Life Cycle |
3.4 Netherlands Disease Modifying Agents Market - Porter's Five Forces |
3.5 Netherlands Disease Modifying Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Disease Modifying Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Disease Modifying Agents Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Netherlands Disease Modifying Agents Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.9 Netherlands Disease Modifying Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Disease Modifying Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the Netherlands |
4.2.2 Rising awareness about the importance of early disease diagnosis and treatment |
4.2.3 Technological advancements in disease-modifying agents |
4.2.4 Growing healthcare expenditure in the Netherlands |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of disease-modifying agents |
4.3.2 High cost associated with disease-modifying agents |
4.3.3 Limited access to specialized healthcare facilities in certain regions of the Netherlands |
5 Netherlands Disease Modifying Agents Market Trends |
6 Netherlands Disease Modifying Agents Market, By Types |
6.1 Netherlands Disease Modifying Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Disease Modifying Agents Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Netherlands Disease Modifying Agents Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 Netherlands Disease Modifying Agents Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 Netherlands Disease Modifying Agents Market Revenues & Volume, By Gene Therapies, 2021 - 2031F |
6.2 Netherlands Disease Modifying Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Disease Modifying Agents Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.2.3 Netherlands Disease Modifying Agents Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.4 Netherlands Disease Modifying Agents Market Revenues & Volume, By Genetic Diseases, 2021 - 2031F |
6.3 Netherlands Disease Modifying Agents Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Disease Modifying Agents Market Revenues & Volume, By Pharmaceutical, 2021 - 2031F |
6.3.3 Netherlands Disease Modifying Agents Market Revenues & Volume, By Healthcare, 2021 - 2031F |
6.3.4 Netherlands Disease Modifying Agents Market Revenues & Volume, By Biotechnology, 2021 - 2031F |
6.4 Netherlands Disease Modifying Agents Market, By Form |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Disease Modifying Agents Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 Netherlands Disease Modifying Agents Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.4.4 Netherlands Disease Modifying Agents Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.5 Netherlands Disease Modifying Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Disease Modifying Agents Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.3 Netherlands Disease Modifying Agents Market Revenues & Volume, By Offline Retail, 2021 - 2031F |
6.5.4 Netherlands Disease Modifying Agents Market Revenues & Volume, By B2B Sales, 2021 - 2031F |
7 Netherlands Disease Modifying Agents Market Import-Export Trade Statistics |
7.1 Netherlands Disease Modifying Agents Market Export to Major Countries |
7.2 Netherlands Disease Modifying Agents Market Imports from Major Countries |
8 Netherlands Disease Modifying Agents Market Key Performance Indicators |
8.1 Patient adherence rate to disease-modifying agent treatments |
8.2 Number of healthcare facilities offering disease-modifying agents |
8.3 Rate of adoption of new disease-modifying agents in the market |
9 Netherlands Disease Modifying Agents Market - Opportunity Assessment |
9.1 Netherlands Disease Modifying Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Disease Modifying Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Disease Modifying Agents Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Netherlands Disease Modifying Agents Market Opportunity Assessment, By Form, 2021 & 2031F |
9.5 Netherlands Disease Modifying Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Disease Modifying Agents Market - Competitive Landscape |
10.1 Netherlands Disease Modifying Agents Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Disease Modifying Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here